Compugen, an Israeli cancer immunotherapy company that calls itself a pioneer in computational target discovery, has ...

The Russian authorities are preparing for a further reduction of the share of imported drugs in the domestic public ...

Belgian clinical-stage biotech iTeos Therapeutics (Nasdaq: ITOS) saw its shar leap18.6% to $8.20 today, despite posting ...

Privately-held Remedy Plan Therapeutics, a US pharma company developing novel, hyperbolic NAMPT inhibitors, has raised more ...

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved Adzynma (apadamtase alfa/cinaxadamtase alfa; ...

Swedish biotech Hansa Biopharma (Nasdaq Stockholm: HNSA) has appointed Maria Törnsén as chief operating officer and president ...

They are the two drugs of the moment, the weight loss products promising a miraculous solution to obesity and—in data ...

Swedish contract development and manufacturing firm Recipharm and France-based regulatory specialist ProductLife Group (PLG) ...

Denmark’s Novo Nordisk has presented data at the European Congress of Obesity (ECO) showing that Wegovy (semaglutide ...

Swiss pharma giant Roche (ROG: SIX), the Breast International Group (BIG), Institut Jules Bordet Clinical Trials Support Unit ...

India has declined the UK's request to include a 'data exclusivity' clause in the proposed Free Trade Agreement (FTA), as ...

US biotech Genentech and its parent, Swiss pharma giant Roche (ROG: SIX), have announced plans to invest more than $700 ...